Elevated levels of insulin-like growth factor binding protein-2 (IGFBP-2) have been linked with the development of dementia and Alzheimer’s disease (AD) and poor cognitive function, according to research presented at EAN 2019.
News News Daily digests from key neurology conferences, written by on-site medical journalists.